Equifax (EFX) CEO discloses insider holdings and GRAT shares in filing

Rhea-AI Filing Summary

Equifax Inc. CEO and director Form 4 filing details insider share activity. On 12/31/2025, a reporting person had 997 shares of Equifax common stock withheld in a transaction coded "F" at a price of $216.98 per share, typically indicating shares withheld to cover taxes on equity awards. After this transaction, the insider directly beneficially owned 142,091 shares of common stock. The insider also held additional indirect interests through several grantor retained annuity trusts (GRATs), including 10,500 shares in a 2-year 2025 GRAT, 21,284 shares in a 2-year December 2025 GRAT, 22,045 shares in a 2-year June 2025 GRAT, 12,333 shares in a 2-year May 2025 GRAT, and 16,287 shares in a 3-year July 2024 GRAT. The holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Begor Mark W

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/31/2025		F		997	D	$216.98	142,091(1)	D
Common Stock								10,500	I	2-yr 2025 GRAT
Common Stock								21,284	I	2-yr Dec 2025 GRAT
Common Stock								22,045	I	2-yr Jun 2025 GRAT
Common Stock								12,333	I	2-yr May 2025 GRAT
Common Stock								16,287	I	3-yr Jul 2024 GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

	/s/Lisa Stockard as Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Equifax Inc (EFX) report in this Form 4?

The filing shows a transaction on 12/31/2025 where the reporting person had 997 shares of Equifax common stock withheld in a transaction coded "F" at $216.98 per share, typically used for tax withholding on equity awards.

How many Equifax (EFX) shares does the insider own directly after this transaction?

Following the reported transaction, the insider directly beneficially owned 142,091 shares of Equifax common stock.

What indirect Equifax (EFX) holdings does the insider report through GRATs?

The insider reports indirect ownership through several GRATs: 10,500 shares in a 2-year 2025 GRAT, 21,284 shares in a 2-year December 2025 GRAT, 22,045 shares in a 2-year June 2025 GRAT, 12,333 shares in a 2-year May 2025 GRAT, and 16,287 shares in a 3-year July 2024 GRAT.

What is the relationship of the reporting person to Equifax Inc (EFX)?

The reporting person is both a director and an officer of Equifax Inc, serving as CEO.

Does the Equifax (EFX) insider hold shares through an employee stock purchase plan?

Yes. The reported holdings include 199 shares of common stock purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan, along with accrued dividend equivalent units tied to restricted stock units.

Is this Equifax (EFX) Form 4 filed by one or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, not by a group.